|
œX‰º@—³ˆêi‚à‚肵‚½@‚è‚イ‚¢‚¿j
@‘åã‘åŠw•‹³Žö ‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È @ˆâ“`ŽqŽ¡—ÊwE‰Á—îˆãŠw
@ƒAƒ“ƒWƒFƒXMGiŠ”jŽæ’÷–ð
yu‰‰ƒe[ƒ}z
@ŠÖ¼‚ªƒoƒCƒI‚ÌŽñ“s‚Æ‚È‚é“ú
@`‘åŠw‚Ì’m‚ÌŽY‹Æ‰»‚ÉŒü‚¯‚Ä` |
|
uŽt—ª—ð |
‚P‚X‚U‚Q”N |
¶‚Ü‚ê |
‚P‚X‚W‚V”N |
‘åã‘åŠwˆãŠw•” ‘²‹Æ |
‚P‚X‚X‚P”N |
‘åã‘åŠwˆãŠw•” ˜V”N•auÀ‘åŠw‰@ ‘²‹Æ
ƒXƒ^ƒ“ƒtƒH[ƒh‘åŠw zŠÂŠí‰È Œ¤‹†ˆõ |
‚P‚X‚X‚U”N |
‘åã‘åŠwˆãŠw•” •Žè ˜V”N•aˆãŠw‹³Žº |
‚P‚X‚X‚W”N |
‘åã‘åŠwˆãŠw•” uŽt
‘åã‘åŠw•‹³Žö ‘åŠw‰@ˆãŠwŒnŒ¤‹†‰Èˆâ“`ŽqŽ¡—Êw
‘åã‘åŠw•‹³Žö ‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È‰Á—îˆãŠwiŒ“”Cj
ƒƒhƒW[ƒ“ƒoƒCƒIƒTƒCƒGƒ“ƒXŽÐ Ý—§ |
‚Q‚O‚O‚O”N |
`‘åŠw ‹qˆõ‹³Žö
ƒƒhƒW[ƒ“ƒoƒCƒIƒTƒCƒGƒ“ƒXŽÐiŒ»AƒAƒ“ƒWƒFƒXMGŽÐjŽæ’÷–ðŒ“‹Æ
|
ŽóÜ—ð |
‚P‚X‚X‚S”N |
‘Û‚ŒŒˆ³Šw‰ïƒfƒ€ƒXŽáŽè§—ãÜ |
‚P‚X‚X‚U”N |
•½¬8”N“x“ú–{zŠÂŠíŠw‰ïŽáŽèŒ¤‹†§—ãÜÅ—DGÜ
ƒAƒƒŠƒJ‚ŒŒˆ³•]‹c‰ïHarry GoldbrattÜ |
‚P‚X‚X‚V”N |
‘Û“®–¬d‰»Šw‰ïŽáŽè§—ãÜ |
‚P‚X‚X‚W”N |
‘æ‚V‚P‰ñ“ú–{“à•ª”åŠw‰ïŽáŽèŒ¤‹†§—ãÜ |
‚P‚X‚X‚X”N |
“ú–{–ò—Šw‰ï‘æ‚P‚S‰ñŠwp§—ãÜ “ú–{ˆãŽt‰ïŒ¤‹†§—ãÜ |
‚Q‚O‚O‚P”N |
“ú–{‚ŒŒˆ³Šw‰ïŽáŽèŒ¤‹†§—ãÜ
“ú–{SŒŒŠÇ“à•ª”åŠw‰ï‚•ô÷‹gŒ¤‹†§—ãÜ |
‚Q‚O‚O‚Q”N |
“ú–{zŠÂŠíŠw‰ï²“¡Ü |
Editorial
Board |
‚P‚X‚X‚W”N` |
Circulation Research |
‚P‚X‚X‚X”N` |
Circulation
Journal of Atherosclerosis and Thrombosis |
‚Q‚O‚O‚O”N` |
Japanese Circulation Journal
Current Drug Targets
Current Gene Therapy
Heart
Journal of Hypertension |
‘ΊOŠˆ“® |
‚P‚X‚X‚X”N |
“ú–{ŒoÏV•· ŠÖ¼‚Q‚P¢‹Ií—ªˆÏˆõ‰ï ƒoƒCƒI¬ˆÏˆõ‰ïˆÏˆõ i`‚Q‚O‚O‚P”Nj |
‚Q‚O‚O‚O”N |
’m“IàŽYŒ¤‹†Šuˆã—Õª–ì‚É‚¨‚¯‚é @“Á‹–•ÛŒì‚Ì‚ ‚è•û‚ÉŠÖ‚·‚é’²¸Œ¤‹†vˆÏˆõ‰ïˆÏˆõi`‚Q‚O‚O‚P”Nj |
‚Q‚O‚O‚P”N |
‘åã¤H‰ï‹cŠuƒoƒCƒIî•ñƒnƒCƒEƒF[ŒŸ“¢‰ï‹cvÀ’· i`‚Q‚O‚O‚Q”Nj
ŒoÏŽY‹ÆÈ\‘¢‰üŠvR‹c‰ï ’m“IàŽY•”–åˆÏˆõ
“ú–{ŒoÏV•· “sŽsĶˆÏˆõ‰ïˆÏˆõ |
‚Q‚O‚O‚Q”N |
•¶•”‰ÈŠwÈuŒ¤‹†—pŽ‘Œ¹‚ÌŽæ‚舵‚¢‚ÉŠÖ‚·‚錟“¢‰ï‹cvˆÏˆõ i`‚Q‚O‚O‚Q”Nj
ŠÖ¼ƒoƒCƒI„i‰ï‹cuŠÖ¼Œ—ƒ‰ƒCƒtƒTƒCƒGƒ“ƒX‚Ì‘Û‹’“_Œ`¬ Šî–{\¬ŒŸ“¢‰ï‹cvÀ’·
“àŠt•{‘‡‰ÈŠw‹Zp‰ï‹cê–åˆÏˆõuŒ¤‹†ŠJ”Œ^ƒxƒ“ƒ`ƒƒ[Žx‰‡v @@@‚Ù‚© |